In this work, new polyoxymethylene (POM)/hydroxyapatite (HAp) nanocomposites for long‐term bone implants have been obtained via extrusion and injection molding processes and characterized by differential scanning calorimetry (DSC), temperature‐modulated DSC (TMDSC), scanning electron microscopy (SEM), transmission electron microscopy (TEM), wide‐angle X‐ray diffraction (WAXD), Fourier transform infrared spectroscopy (FTIR), thermogravimetry (TG), and tensile mechanical and in vitro stability tests. Based on the DSC results, it was found that the degree of crystallinity increases for POM/0.5% HAp sample and decreases for POM/1.0% HAp and POM/2.5% HAp. SEM and TEM observations for POM/HAp nanocomposites indicated that the dispersion of HAp in the polymer matrix was uniform and the diameter of the HAp particles was less than 100 nm for most of them. Young's modulus increases with increasing HAp concentration, whereby elongation at break decreases. On the contrary, HAp concentration does not have a significant influence on the tensile strength. TG results show that for POM/0.5% HAp, POM/1.0% HAp, and POM/2.5% HAp, thermal stability slightly increases in comparison to pure POM, whereas for POM/5.0 HAp and POM/10.0% HAp, lower thermal stability was observed. In vitro data reveal that with an increase of HAp content, bioactivity of nanocomposites increases; a good in vitro chemical stability of POM and POM nanocomposites was confirmed. Copyright © 2011 John Wiley & Sons, Ltd.